CUREAGE THERAPEUTICS LTD

Active London

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
C

CUREAGE THERAPEUTICS LTD

Research and experimental development on biotechnology

Founded 23 Aug 2024 Active London, England 0 employees website.com
Research and experimental development on biotechnology

Previous Company Names

HERMOGEN BIO LTD 23 Aug 2024 — 12 Dec 2024
Accounts Submitted 25 Feb 2026 Next due 23 May 2026 18 days remaining
Confirmation Submitted 20 Aug 2025 Next due 3 Sept 2026 4 months remaining
Net assets £140K
Total assets £150K
Total Liabilities £10K
Charges None No charges registered

Contact & Details

Contact

Registered Address

16 Stapleton Court Packington Road London W3 8FB England

Website

www.example.com

Full company profile for CUREAGE THERAPEUTICS LTD (15913754), an active company based in London, England. Incorporated 23 Aug 2024. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2025–2025)

Cash in Bank

£88.25k

Net Assets

£140.21k

Total Liabilities

£9.63k

Turnover

N/A

Employees

N/A

Debt Ratio

6%

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
P&L
Revenue
£142.3M
Gross Profit
£48.2M
Operating Profit
£22.4M
Net Profit
£18.1M
EBITDA
£31.5M
Assets
Cash
£24.7M
Total Assets
£89.4M
Liabilities
Total Liabilities
£45.2M
Key Metrics
Employees
1,247
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 23,636 Shares £260k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
19 Dec 202423,636£260k£11

Officers

Officers

2 active 1 resigned
Status
Gonzalo Fernandez-miranda PerezDirectorSpanishSpain4523 Aug 2024Active
Liron ElkoubyDirectorIsraeliIsrael456 Mar 2025Active

Shareholders

Shareholders (6)

Gonzalo Fernandez-miranda Perez
30.8%
35,000
Liron Elkouby
30.8%
35,000

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Liron Elkouby

Israeli

Active
Notified 23 Aug 2024
Residence Israel
DOB September 1980
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors

Gonzalo Fernandez-miranda Perez

Spanish

Active
Notified 23 Aug 2024
Residence Spain
DOB May 1981
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
14 Apr 2026OfficersAppointment of Deep Science Ventures Limited as director on 30 Mar 2025
14 Apr 2026OfficersTermination of Kerstin Papenfuss as director on 30 Mar 2025
25 Feb 2026AccountsAnnual accounts made up to 31 Aug 2025
10 Sept 2025Persons With Significant ControlChange to Dr Gonzalo Fernandez-Miranda Perez as a person with significant control on 1 Sept 2025
9 Sept 2025OfficersChange to director Maria Montserrat Montaner Picart on 6 Mar 2025
14 Apr 2026 Officers

Appointment of Deep Science Ventures Limited as director on 30 Mar 2025

14 Apr 2026 Officers

Termination of Kerstin Papenfuss as director on 30 Mar 2025

25 Feb 2026 Accounts

Annual accounts made up to 31 Aug 2025

10 Sept 2025 Persons With Significant Control

Change to Dr Gonzalo Fernandez-Miranda Perez as a person with significant control on 1 Sept 2025

9 Sept 2025 Officers

Change to director Maria Montserrat Montaner Picart on 6 Mar 2025

Recent Activity

Latest Activity

Appointment of Deep Science Ventures Limited as director on 30 Mar 2025

2 weeks ago on 14 Apr 2026

Termination of Kerstin Papenfuss as director on 30 Mar 2025

2 weeks ago on 14 Apr 2026

Annual accounts made up to 31 Aug 2025

2 months ago on 25 Feb 2026

Change to Dr Gonzalo Fernandez-Miranda Perez as a person with significant control on 1 Sept 2025

7 months ago on 10 Sept 2025

Change to director Maria Montserrat Montaner Picart on 6 Mar 2025

7 months ago on 9 Sept 2025